title: [Visual loss after pars plana vitrectomy with membrane peeling].
authors.affiliation: Universitäts-Augenklinik Münster, Albert-Schweitzer-Campus 1, Gebäude D15, 48149, Münster, Deutschland, m.schmidt@uni-muenster.de.
authors.forename: M
authors.initials: M
authors.lastname: Schmidt
authors.forename: N
authors.initials: N
authors.lastname: Schrage
authors.forename: C
authors.initials: C
authors.lastname: Clemens
authors.forename: N
authors.initials: N
authors.lastname: Eter
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D001766:Blindness / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control*; D019773:Epiretinal Membrane / Q000601:surgery*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012163:Retinal Detachment / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D016896:Treatment Outcome; D014821:Vitrectomy / Q000009:adverse effects*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab